AQR Capital Management’s Prelude Therapeutics PRLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$35.3K Buy
43,647
+9,824
+29% +$7.95K ﹤0.01% 3256
2025
Q1
$26K Buy
33,823
+21,330
+171% +$16.4K ﹤0.01% 3117
2024
Q4
$15.9K Buy
+12,493
New +$15.9K ﹤0.01% 2850